RTRobert E. Tigelaar

Robert E. Tigelaar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert E. Tigelaar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Adrian Hayday

    Francis Crick Institute, London, UK

    2 shared publications
  • Michael Girardi

    Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, Connecticut 06520, USA

    2 shared publications
  • Renata B. Filler

    Department of Dermatology and the Yale Skin Diseases Research Core Center

    2 shared publications
  • Earl Glusac

    Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520

    1 shared publication
  • Efstathios Theodoridis

    Peter Gorer Department of Immunobiology, Guy's King's St Thomas' School of Medicine, Guy's Hospital, London, United Kingdom

    1 shared publication
  • Hao Feng

    Department of Dermatology, Yale University, School of Medicine, New Haven, CT, USA

    1 shared publication

Latest Publications

  • Anti‐inflammatory effects in the skin of thymosin‐β4 splice‐variants

    by Michael Girardi, Michael A. Sherling, Renata B. Filler, John Shires, Efstathios Theodoridis, Adrian C. Hayday, Robert E. Tigelaar

    Summary: The intraepithelial lymphocyte (IEL) network of T‐cell receptor γδ+ (Vγ5+) dendritic epidermal T cells (DETC) in murine skin down‐regulates cutaneous inflammation, although the mechanism is unknown. Thymosin‐β4 (Tβ4), identified by serial analysis of gene expression as a predominant transcript in gut IEL, encodes both a ubiquitous actin‐binding protein (UTβ4) with demonstrated capacity to inhibit neutrophilic infiltration, and a splice‐variant limited to lymphoid tissue (LTβ4) with unknown bioactivity. Freshly isolated Vγ5+ DETCs expressed both forms, while only LTβ4 was preferentially up‐regulated after cellular activation in vitro. To compare the anti‐inflammatory properties of LTβ4 and UTβ4 in the skin in vivo, the biological activities of synthesized polypeptides were assessed using three different strategies: neutrophil infiltration by footpad λ‐carrageenan injection; irritant contact dermatitis to 12‐O‐tetradecanoylphorbol 13‐acetate; and allergic contact dermatitis to 2,4‐dinitrofluorobenzene. These studies clearly showed that the anti‐inflammatory activities of LTβ4 were broader and most often stronger than those of UTβ4. Thus, the activation‐responsive expression of the lymph‐specific form of Tβ4 may be one mechanism by which DETC, and possibly other IELs, down‐regulate local inflammation.


  • Open Access

    Resident Skin-specific γδ T Cells Provide Local, Nonredundant Regulation of Cutaneous Inflammation

    by Michael Girardi, Julia Lewis, Earl Glusac, Renata B. Filler, Liping Geng, Adrian C. Hayday, Robert E. Tigelaar

    The function of the intraepithelial lymphocyte (IEL) network of T cell receptor (TCR) γδ+ (Vγ5+) dendritic epidermal T cells (DETC) was evaluated by examining several mouse strains genetically deficient in γδ T cells (δ−/− mice), and in δ−/− mice reconstituted with DETC or with different γδ cell subpopulations. NOD.δ−/− and FVB.δ−/− mice spontaneously developed localized, chronic dermatitis, whereas interestingly, the commonly used C57BL/6.δ−/− strain did not. Genetic analyses indicated a single autosomal recessive gene controlled the dermatitis susceptibility of NOD.δ−/− mice. Furthermore, allergic and irritant contact dermatitis reactions were exaggerated in FVB.δ−/−, but not in C57BL/6.δ−/− mice. Neither spontaneous nor augmented irritant dermatitis was observed in FVB.β−/− δ−/− mice lacking all T cells, indicating that αβ T cell–mediated inflammation is the target for γδ-mediated down-regulation. Reconstitution studies demonstrated that both spontaneous and augmented irritant dermatitis in FVB.δ−/− mice were down-regulated by Vγ5+ DETC, but not by epidermal T cells expressing other γδ TCRs. This study demonstrates that functional impairment at an epithelial interface can be specifically attributed to absence of the local TCR-γδ+ IEL subset and suggests that systemic inflammatory reactions may more generally be subject to substantial regulation by local IELs.